Genzyme Clolar Approved For Pediatric Acute Lymphoblastic Leukemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Indication follows advisory committee recommendation to approve clofarabine for ALL but not for pediatric acute myelogenous leukemia. Genzyme will have to redesign its confirmatory trial within two months.